International Trade Bulletin - Volume 1, Issue 7
Client Alert | 2 min read | 06.12.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CUSTOMS IN THE SPOTLIGHT
- REGULATIONS: Recent Regulations Proposed by Department of State Will Make U.S. Agency Regulators More Accountable for Regulatory Commitments Abroad
- PHARMACEUTICALS: Pharmaceutical Companies May Face Override of Patent Rights for Public Health Concerns
- FREE TRADE AGREEMENTS: Multi-National Firms Use Southeast Asian FTAs to Enter Indian Markets Demonstrating the Benefits of FTAs to Non-FTA Party Companies
- WTO: New Agreement Among WTO Members Could Allow Foreign Companies Greater Access to Taiwan's Government Procurement Market
- ANTI-DUMPING IN THE EU : European Commissioner for Trade, Peter Mandleson, announces review to decide the best way of balancing competing commercial interests in enforcing EU anti-dumping policy
- EXPORT CONTROLS: BIS Reaffirms Deemed Export Rules By Formally Withdrawing Advance Notice of Proposed Rulemaking
- C-TPAT: C-TPAT Establishes Mandatory Security Link Portal
Contacts
Insights
Client Alert | 11 min read | 12.15.25
New York LLC Transparency Act: Key Requirements and Deadlines
On January 1, 2026 (“Effective Date”), the New York LLC Transparency Act ("New York Act”) is scheduled to take effect, introducing new disclosure requirements for limited liability companies (“LLCs”) formed or registered to do business in New York State. The New York Act is expected to impose the type of broad beneficial ownership requirements the federal CTA and rules implementing it was designed to require, before the federal government’s decision to limit the scope of the CTA’s beneficial ownership reporting requirements to foreign companies and foreign beneficial owners.
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
